FDA reviewing heart risks of Glaxo diabetes pillWASHINGTON (AP) â€" The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster drug Avandia, which was severely restricted in 2010 due to concerns about its impact on the heart.
Source: FDA reviewing heart risks of Glaxo diabetes pill (http://news.yahoo.com/fda-reviewing-heart-risks-glaxo-diabetes-pill-211708765--finance.html)